Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Skysona
Special Reports
UPDATED: Most expensive drugs in the US in 2025
One-dose gene therapies with multimillion-dollar price tags make up the top 10 most expensive drugs in the U.S.
Zoey Becker
,
Kevin Dunleavy
,
Eric Sagonowsky
,
Angus Liu
,
Fraiser Kansteiner
Aug 11, 2025 3:00am
FDA restricts bluebird's gene therapy after blood cancer reports
Aug 8, 2025 11:19am
bluebird investors get on board with sale to Carlyle, SK Capital
May 30, 2025 11:50am
FDA considers 'regulatory action' for bluebird's Skysona
Dec 2, 2024 11:22am
Bluebird down 18% with slow uptake of SCD gene therapy Lyfgenia
Aug 14, 2024 12:07pm
HHS provides unfavorable opinion on bluebird's fertility program
Jul 22, 2024 5:26pm